Aarhus University logo

    • About
      • About the Nordic EMBL Partnership
      • Mission statement
      • EMBL non-tenure model
      • Contact
    • News
    • Collaborations
      • NORPOD - Postdoctoral Researcher Programme
      • NordForsk: Nordic EMBL Partnership Hub
      • How the Nordic EMBL Partnership is helping to fight COVID-19
      • Tools of the Trade Data Science Webinar Series
      • Nordic EMBL Partnership Meetings
      • Nordic EMBL Partnership Science and Art
    • Research
    • Technologies
    • Training
    • Careers
    • Internal

    Read more

    Click here to read more

    DANDRITE

    The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

    FIMM

    The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

    MIMS

    The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

    NCMBM

    The Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) is the Norwegian node of the Nordic EMBL Partnership. NCMBM conducts molecular medicine & biotech research and works to translate these findings into clinical practice. 

    News from the Partnership


    Where are they now? Meet Mari Bonde: stepping from academia into biotech industry

    Mari Bonde in a dark top with flowers with a green outdoor background
    14 February 2022 - People

    The “Where Are They Now? Nordic EMBL Partnership Alumni Careers” profile series introduces readers to alumni of the Nordic EMBL Partnership and the…

    Taro Kitazawa appointed new Group Leader at DANDRITE

    Taro in a gray shirt on a light background
    13 February 2022 - Research news

    Taro Kitazawa will start his research activities on molecular basis of neuroplasticity in memory formation in the summer 2022.

    Largest ge­netic study of mi­graine to date re­veals new ge­netic risk factors

    Image of a brain with a DNA strand in front of it
    10 February 2022 - Research news

    An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine. The…

    Congratulations to the Art and Science Contest Winners!

    An acrylic painting on canvas and gold leaf of a rain shower with a person holding an umbrella
    10 February 2022 - Knowledge exchange

    Three scientist-artists win the 5th Nordic EMBL Partnership Science and Art Competition.

    Page 39 of 70.

    • Previous
    • 1
    • …
    • 38
    • 39
    • 40
    • …
    • 70
    • Next

    Upcoming Partnership Events


    No events found.

    Follow us!

    Follow us for the latest updates and insights! Join our community and stay connected with us on the following platforms

    LinkedIn
    Bluesky
    X

     

    About 

    News 

    Collaborations

    Research

    Technologies

    Training

    Careers

     

     

     

    Follow us

    X: @NordicEMBL

    LinkedIn: linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

     

    The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

     

    Revised 21.03.2025

    © — Cookies at au.dk
    Privacy Policy
    Accessibility Statement

    15450 / i43